OnKure Therapeutics, Inc. (OKUR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 39.2M |
| Enterprise Value | -19.3M |
| P/E Ratio | -1 |
| PEG Ratio | -0.13 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.32 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 2.29 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.3 |
| Return On Equity | -0.61 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -830,000 |
| EBITDA | -58.69M |
| Net Income | -59.52M |
| Diluted EPS | -4.4 |
Balance Sheet
| Total Cash | 192.11M |
| Total Cash/Share | 14.05 |
| Total Debt | 409,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 13.78 |
| Book Value Per Share | 13.48 |
Price History
| 52-Week Change | 69.53 |
| 52-Week High | 5.38 |
| 52-Week Low | 1.91 |
| Moving Average 50 Days | 4.28 |
| Moving Average 200 Days | 3.35 |
Statistics
| Average Volume | 369,287 |
| Shares Outstanding | 13.67M |
| % Held by Institutions | 203.62 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | October 07, 2024 |
AD
